Based on the epigenetic regulation of tumor cGAS by TET2 synergized with STAT5A signaling, stimulating TET2 activity by VC triggers tumor cGAS-cGAMP-endothelial STING pathway activation and induces tumor vascular normalization, thereby potentiating immunotherapy efficacy. This evidence concerns the gene STAT5A and neoplasm.